AAAAAA
Results: 26-50/54
Authors:
JOHNSON RE
EISSENBERG T
STITZER ML
STRAIN EC
LIEBSON IA
BIGELOW GE
Citation: Re. Johnson et al., BUPRENORPHINE TREATMENT OF OPIOID DEPENDENCE - CLINICAL-TRIAL OF DAILY VERSUS ALTERNATE-DAY DOSING, Drug and alcohol dependence, 40(1), 1995, pp. 27-35
Authors:
GREENFIELD L
BIGELOW GE
BROONER RK
Citation: L. Greenfield et al., VALIDITY OF INTRAVENOUS DRUG-ABUSERS SELF-REPORTED CHANGES IN HIV HIGH-RISK DRUG-USE BEHAVIORS, Drug and alcohol dependence, 39(2), 1995, pp. 91-98
Authors:
HABERNY KA
WALSH SL
GINN DH
WILKINS JN
GARNER JE
SETODA D
BIGELOW GE
Citation: Ka. Haberny et al., ABSENCE OF ACUTE COCAINE INTERACTIONS WITH THE MAO-B INHIBITOR SELEGILINE, Drug and alcohol dependence, 39(1), 1995, pp. 55-62
Authors:
KENDALL JC
SHERMAN MF
BIGELOW GE
Citation: Jc. Kendall et al., PSYCHIATRIC-SYMPTOMS IN POLYSUBSTANCE ABUSERS - RELATIONSHIP TO RACE,SEX, AND AGE, Addictive behaviors, 20(5), 1995, pp. 685-690
Authors:
KIDORF M
SHERMAN MF
JOHNSON JG
BIGELOW GE
Citation: M. Kidorf et al., ALCOHOL EXPECTANCIES AND CHANGES IN BEER CONSUMPTION OF 1ST-YEAR COLLEGE-STUDENTS, Addictive behaviors, 20(2), 1995, pp. 225-231
Authors:
BIGELOW GE
Citation: Ge. Bigelow, EDITING THE COMEDIA - MCGAHA,M, CASA,FP, Critica hispanica, 17(1), 1995, pp. 146-147
Authors:
BIGELOW GE
Citation: Ge. Bigelow, SAVAGE ACTS, 4 PLAYS - VALLEINCLAN,RD, LIMA,R, TRANSLATOR, Estreno, 21(2), 1995, pp. 57-58
Authors:
WALSH SL
PRESTON KL
BIGELOW GE
STITZER ML
Citation: Sl. Walsh et al., ACUTE ADMINISTRATION OF BUPRENORPHINE IN HUMANS - PARTIAL AGONIST ANDBLOCKADE EFFECTS, The Journal of pharmacology and experimental therapeutics, 274(1), 1995, pp. 361-372
Authors:
STRAIN EC
PRESTON KL
LIEBSON IA
BIGELOW GE
Citation: Ec. Strain et al., BUPRENORPHINE EFFECTS IN METHADONE-MAINTAINED VOLUNTEERS - EFFECTS AT2 HOURS AFTER METHADONE, The Journal of pharmacology and experimental therapeutics, 272(2), 1995, pp. 628-638
Authors:
STRAIN EC
STITZER ML
LIEBSON IA
BIGELOW GE
Citation: Ec. Strain et al., BUPRENORPHINE VERSUS METHADONE IN THE TREATMENT OF OPIOID-DEPENDENT COCAINE USERS, Psychopharmacology, 116(4), 1994, pp. 401-406
Authors:
STRAIN EC
PRESTON KL
STITZER ML
LIEBSON IA
BIGELOW GE
Citation: Ec. Strain et al., THE EFFECTS OF COCAINE IN BUPRENORPHINE-MAINTAINED OUTPATIENT VOLUNTEERS - RESULTS FROM CLINICAL-EXPERIENCE AND LABORATORY CHALLENGES, The American journal on addictions, 3(2), 1994, pp. 129-143
Authors:
WALSH SL
GILSON SF
JASINSKI DR
STAPLETON JM
PHILLIPS RL
DANNALS RF
SCHMIDT J
PRESTON KL
GRAYSON R
BIGELOW GE
SULLIVAN JT
CONTOREGGI C
LONDON ED
Citation: Sl. Walsh et al., BUPRENORPHINE REDUCES CEREBRAL GLUCOSE-METABOLISM IN POLYDRUG ABUSERS, Neuropsychopharmacology, 10(3), 1994, pp. 157-170
Authors:
STRAIN EC
STITZER ML
LIEBSON IA
BIGELOW GE
Citation: Ec. Strain et al., OUTCOME AFTER METHADONE TREATMENT - INFLUENCE OF PRIOR TREATMENT FACTORS AND CURRENT TREATMENT STATUS, Drug and alcohol dependence, 35(3), 1994, pp. 223-230
Authors:
KING VL
BROONER RK
BIGELOW GE
FELCH LJ
GAZAWAY PM
SCHMIDT CW
Citation: Vl. King et al., CONDOM USE RATES FOR SPECIFIC SEXUAL BEHAVIORS AMONG OPIOID ABUSERS ENTERING TREATMENT, Drug and alcohol dependence, 35(3), 1994, pp. 231-238
Authors:
ROUSAR E
BROONER RK
REGIER MW
BIGELOW GE
Citation: E. Rousar et al., PSYCHIATRIC DISTRESS IN ANTISOCIAL DRUG-ABUSERS - RELATION TO OTHER PERSONALITY-DISORDERS, Drug and alcohol dependence, 34(2), 1994, pp. 149-154
Authors:
WALSH SL
PRESTON KL
SULLIVAN JT
FROMME R
BIGELOW GE
Citation: Sl. Walsh et al., FLUOXETINE ALTERS THE EFFECTS OF INTRAVENOUS COCAINE IN HUMANS, Journal of clinical psychopharmacology, 14(6), 1994, pp. 396-407
Authors:
UMBRICHTSCHNEITER A
GINN DH
PABST KM
BIGELOW GE
Citation: A. Umbrichtschneiter et al., PROVIDING MEDICAL-CARE TO METHADONE CLINIC PATIENTS - REFERRAL VS ON-SITE CARE, American journal of public health, 84(2), 1994, pp. 207-210
Authors:
PRESTON KL
BIGELOW GE
Citation: Kl. Preston et Ge. Bigelow, DRUG DISCRIMINATION ASSESSMENT OF AGONIST-ANTAGONIST OPIOIDS IN HUMANS - A 3-CHOICE SALINE-HYDROMORPHONE-BUTORPHANOL PROCEDURE, The Journal of pharmacology and experimental therapeutics, 271(1), 1994, pp. 48-60
Authors:
WALSH SL
PRESTON KL
STITZER ML
CONE EJ
BIGELOW GE
Citation: Sl. Walsh et al., CLINICAL-PHARMACOLOGY OF BUPRENORPHINE - CEILING EFFECTS AT HIGH-DOSES, Clinical pharmacology and therapeutics, 55(5), 1994, pp. 569-580
Authors:
PRESTON KL
BIGELOW GE
Citation: Kl. Preston et Ge. Bigelow, DISCRIMINATIVE STIMULUS EFFECTS OF HYDROMORPHONE, BUTORPHANOL, AND PENTAZOCINE AFTER PRETREATMENT WITH NALTREXONE OR PLACEBO, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 131-131
Authors:
JOHNSON RE
STITZER ML
STRAIN EC
BIGELOW GE
FELCH LJ
LIEBSON IA
Citation: Re. Johnson et al., A PLACEBO (P) CONTROLLED CLINICAL-TRIAL OF BUPRENORPINE (B) FOR THE TREATMENT OF OPIATE DEPENDENCE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 131-131
Authors:
STRAIN EC
STITZER ML
LIEBSON IA
BIGELOW GE
Citation: Ec. Strain et al., COMPARISON OF BUPRENORPHINE AND METHADONE IN THE TREATMENT OF OPIOID DEPENDENCE, The American journal of psychiatry, 151(7), 1994, pp. 1025-1030
Authors:
STRAIN EC
STITZER ML
LIEBSON IA
BIGELOW GE
Citation: Ec. Strain et al., METHADONE DOSE AND TREATMENT OUTCOME, Drug and alcohol dependence, 33(2), 1993, pp. 105-117
Authors:
BIGELOW GE
Citation: Ge. Bigelow, 'CANTON' - MARTININIESTA,F, Estreno, 19(2), 1993, pp. 51-52
Authors:
STRAIN EC
PRESTON KL
LIEBSON IA
BIGELOW GE
Citation: Ec. Strain et al., PRECIPITATED WITHDRAWAL BY PENTAZOCINE IN METHADONE-MAINTAINED VOLUNTEERS, The Journal of pharmacology and experimental therapeutics, 267(2), 1993, pp. 624-634